Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tauns Laboratories, Inc. ( (JP:197A) ) has provided an announcement.
Tauns Laboratories, Inc. reported a significant decline in its financial performance for the three months ended September 30, 2025, with net sales and income figures showing substantial decreases compared to the previous year. Despite the downturn, the company maintains its forecast for FY2026, indicating a moderate increase in net sales and a notable rise in net income, suggesting a potential recovery and strategic adjustments to improve its financial health.
The most recent analyst rating on (JP:197A) stock is a Buy with a Yen627.00 price target. To see the full list of analyst forecasts on Tauns Laboratories, Inc. stock, see the JP:197A Stock Forecast page.
More about Tauns Laboratories, Inc.
Tauns Laboratories, Inc. is a company listed on the Tokyo Stock Exchange, operating in the laboratory and diagnostics industry. The company focuses on developing and providing diagnostic solutions and products, catering to a diverse market that requires precise and reliable laboratory testing services.
Average Trading Volume: 466,114
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen59.24B
See more insights into 197A stock on TipRanks’ Stock Analysis page.